Cosmos Health corrects reverse split date to Nov. 13, 2026

Q: What is COSM's reverse stock split ratio and effective date?

Cosmos Health's reverse stock split is 1-for-20 and will be effective November 13, 2026. The Certificate of Amendment is to become effective at 4 p.m. local time on November 12, 2026.

The board maintained authorized shares at 1,500,000,000 common and 300,000,000 preferred.

Available on EDGAR 11/10/2026 - 05:28 PM EST Accepted by SEC EDGAR 11/10/2026 - 05:28 PM EST

Filing Impact

(Moderate)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K/A

Rhea-AI Filing Summary

Cosmos Health Inc. corrected the stated dates for its 1-for-20 reverse stock split: the split will be effective November 13, 2026, and the Certificate of Amendment is to become effective at 4 p.m. local time on November 12, 2026.

Filing Explained

The filed 1-for-20 reverse split will consolidate each 20 outstanding common shares into one, while the company keeps its 1.5 billion authorized common shares unchanged; the charter’s authorized-share ceiling therefore does not shrink with the outstanding share count.

8-K Event Classification

3 items: 3.03, 5.03, 9.01

3 items

Item 3.03 Material Modification to Rights of Security Holders Securities

A change was made that materially affects the rights of existing shareholders (e.g., dividend rights, voting rights).

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Reverse stock split ratio: 1-for-20 Authorized common shares: 1,500,000,000 shares Authorized preferred shares: 300,000,000 shares +1 more

4 metrics

Reverse stock split ratio 1-for-20 Approved by the board

Authorized common shares 1,500,000,000 shares Maintained by the board

Authorized preferred shares 300,000,000 shares Maintained by the board

Reverse stock split effective date November 13, 2026 Date stated for the reverse stock split

Key Terms

Reverse Stock Split, Certificate of Amendment, authorized shares

3 terms

Reverse Stock Split technical

"approved a stock split ratio of 1-for-20 (the “Reverse Stock Split”)"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

Certificate of Amendment regulatory

"filed a Certificate of Amendment to the Company’s Articles of Incorporation"

A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.

authorized shares technical

"maintained the Company’s authorized shares of common stock"

Authorized shares are the maximum number of shares a company is allowed to issue according to its official plan. Think of it as a company’s set limit on how many pieces of its ownership it can distribute to investors. This number helps investors understand the potential for future growth or change in the company's ownership structure.

Stock Split

1-for-20 reverse split · Effective November 13, 2026

Split Ratio 1-for-20 reverse split

Effective Date November 13, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is COSM's reverse stock split ratio and effective date?

Cosmos Health's reverse stock split is 1-for-20 and will be effective November 13, 2026. The Certificate of Amendment is to become effective at 4 p.m. local time on November 12, 2026.

How many shares will COSM be authorized to issue after the reverse split?

The board maintained authorized shares at 1,500,000,000 common shares and 300,000,000 preferred shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 9, 2026

COSMOS HEALTH INC.

(Exact name of registrant as specified in its charter)

Nevada

000-54436

27-0611758

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

5 Agiou Georgiou, Pilea, Thessaloniki, Greece		55438
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (312) 865-0026

N/A

(Former name or former address, if changed since last report.)

Title of Each Class

Trading

Symbol

Name of Each Exchange

On Which Registered

Common Stock, $.001 par value

COSM

Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

EXPLANATORY NOTE

This Amendment No. 1 on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K (the “Original Report”), initially filed by Cosmos Health Inc. (the “Company”) with the Securities and Exchange Commission earlier today on November 10, 2026. This Amendment is being filed solely to correct a clerical error in Item 5.03. In the second paragraph of the section titled “Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year,” certain dates were corrected. The Reverse Stock Split will be effective on November 13, 2026, and the Certificate of Amendment will be effective on November 12, 2026. Except as set forth in this Amendment, no other modifications have been made to the Original Report, but for ease of reference, this Amendment restates in its entirety the Current Report, as amended.

Item 3.03 Material Modification to Rights of Security Holders.

The information set forth in Item 5.03 below in regard to the Amendment and the Reverse Stock Split (as defined and discussed in Item 5.03) is incorporated in this Item 3.03 by reference.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

As previously disclosed in the Current Report on Form 8-K filed by Cosmos Health Inc. (the “Company”, “we” and “us”) with the Securities and Exchange Commission (the “Commission” or the “SEC”) on October 1, 2025, at the Company’s annual meeting of shareholders, a majority of voting shareholders approved, among other things, the grant of discretionary authority for our Board of Directors to effect a reverse stock split of all of the outstanding common stock of the Company, by the filing of an amendment to our Articles of Incorporation with the Secretary of State of Nevada.

On October 27, 2026, the Board of Directors approved a stock split ratio of 1-for-20 (the “Reverse Stock Split”) and maintained the Company’s authorized shares of common stock at 1,500,000,000 and its Preferred Stock at 300,000,000 shares, effective November 13, 2026. On November 9, 2026, the Company filed a Certificate of Amendment to the Company’s Articles of Incorporation with the Secretary of Nevada to effect the Reverse Stock Split (the “Amendment”), which is to become effective at 4 pm, Local Time, on November 12, 2026.

The forgoing description of the Amendment is qualified in its entirety by reference to the full text of the Amendment, filed herewith as Exhibit 3.1, and incorporated herein by reference in its entirety.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Item		Description
3.1		Certificate of Amendment to Articles of Incorporation of Cosmos Health Inc. (1-for-20 Reverse Stock Split of Common Stock) filed with the Nevada Secretary of State (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on November 10, 2026).
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	COSMOS HEALTH INC.

Date: November 10, 2026	By:	/s/ George Terzis
		George Terzis
		Chief Financial Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents